Suppr超能文献

相似文献

1
Arachidonic acid release mediated by OX1 orexin receptors.
Br J Pharmacol. 2010 Jan;159(1):212-21. doi: 10.1111/j.1476-5381.2009.00535.x. Epub 2009 Dec 4.
2
OX1 orexin/hypocretin receptor activation of phospholipase D.
Br J Pharmacol. 2012 Feb;165(4b):1109-23. doi: 10.1111/j.1476-5381.2011.01565.x.
4
OX1 orexin/hypocretin receptor signaling through arachidonic acid and endocannabinoid release.
Mol Pharmacol. 2012 Aug;82(2):156-67. doi: 10.1124/mol.112.078063. Epub 2012 May 1.
6
The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C.
J Biol Chem. 2000 Oct 6;275(40):30806-12. doi: 10.1074/jbc.M002603200.
7
Orexin receptors couple to Ca2+ channels different from store-operated Ca2+ channels.
Neuroreport. 2001 Jul 3;12(9):2017-20. doi: 10.1097/00001756-200107030-00046.
8
Multiple phospholipase activation by OX(1) orexin/hypocretin receptors.
Cell Mol Life Sci. 2008 Jun;65(12):1948-56. doi: 10.1007/s00018-008-8206-z.
9
Lipid signaling cascades of orexin/hypocretin receptors.
Biochimie. 2014 Jan;96:158-65. doi: 10.1016/j.biochi.2013.06.015. Epub 2013 Jun 28.
10
Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
Endocrinology. 2006 Oct;147(10):4977-84. doi: 10.1210/en.2006-0201. Epub 2006 Jul 20.

引用本文的文献

1
A molecular network map of orexin-orexin receptor signaling system.
J Cell Commun Signal. 2023 Mar;17(1):217-227. doi: 10.1007/s12079-022-00700-3. Epub 2022 Dec 8.
2
Orexin receptors in GtoPdb v.2021.3.
IUPHAR BPS Guide Pharm CITE. 2021;2021(3). doi: 10.2218/gtopdb/f51/2021.3. Epub 2021 Sep 2.
3
Physiological Implications of Orexins/Hypocretins on Energy Metabolism and Adipose Tissue Development.
ACS Omega. 2019 Dec 27;5(1):547-555. doi: 10.1021/acsomega.9b03106. eCollection 2020 Jan 14.
4
Orexin/Hypocretin Signaling.
Curr Top Behav Neurosci. 2017;33:17-50. doi: 10.1007/7854_2016_49.
5
Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?
CNS Drugs. 2014 Aug;28(8):713-30. doi: 10.1007/s40263-014-0179-x.
6
Orexin/hypocretin receptor signalling cascades.
Br J Pharmacol. 2014 Jan;171(2):314-31. doi: 10.1111/bph.12324.
7
Orexin/hypocretin receptor signalling: a functional perspective.
Br J Pharmacol. 2014 Jan;171(2):294-313. doi: 10.1111/bph.12296.
8
OX1 orexin/hypocretin receptor activation of phospholipase D.
Br J Pharmacol. 2012 Feb;165(4b):1109-23. doi: 10.1111/j.1476-5381.2011.01565.x.

本文引用的文献

1
Phospholipase A2 structure/function, mechanism, and signaling.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S237-42. doi: 10.1194/jlr.R800033-JLR200. Epub 2008 Nov 14.
2
Arachidonic acid and ion channels: an update.
Br J Pharmacol. 2008 Sep;155(1):4-16. doi: 10.1038/bjp.2008.216. Epub 2008 Jun 16.
3
Multiple phospholipase activation by OX(1) orexin/hypocretin receptors.
Cell Mol Life Sci. 2008 Jun;65(12):1948-56. doi: 10.1007/s00018-008-8206-z.
4
Guide to Receptors and Channels (GRAC), 3rd edition.
Br J Pharmacol. 2008 Mar;153 Suppl 2(Suppl 2):S1-209. doi: 10.1038/sj.bjp.0707746.
5
IP3-independent signalling of OX1 orexin/hypocretin receptors to Ca2+ influx and ERK.
Biochem Biophys Res Commun. 2007 Feb 9;353(2):475-80. doi: 10.1016/j.bbrc.2006.12.045. Epub 2006 Dec 15.
6
Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.
Br J Pharmacol. 2007 Jan;150(1):97-104. doi: 10.1038/sj.bjp.0706959. Epub 2006 Nov 20.
8
The phospholipase A2 superfamily and its group numbering system.
Biochim Biophys Acta. 2006 Nov;1761(11):1246-59. doi: 10.1016/j.bbalip.2006.07.011. Epub 2006 Aug 3.
9
Lp-PLA2: a new kid on the block.
Clin Chem. 2006 Sep;52(9):1645-50. doi: 10.1373/clinchem.2006.070672. Epub 2006 Jul 27.
10
Properties of the Group IV phospholipase A2 family.
Prog Lipid Res. 2006 Nov;45(6):487-510. doi: 10.1016/j.plipres.2006.05.003. Epub 2006 Jun 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验